全文获取类型
收费全文 | 148篇 |
免费 | 2篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 4篇 |
妇产科学 | 6篇 |
基础医学 | 14篇 |
口腔科学 | 1篇 |
临床医学 | 6篇 |
内科学 | 53篇 |
神经病学 | 4篇 |
特种医学 | 2篇 |
外科学 | 33篇 |
综合类 | 2篇 |
预防医学 | 14篇 |
眼科学 | 1篇 |
药学 | 3篇 |
肿瘤学 | 1篇 |
出版年
2022年 | 4篇 |
2021年 | 4篇 |
2019年 | 1篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 3篇 |
2015年 | 2篇 |
2014年 | 3篇 |
2013年 | 6篇 |
2012年 | 14篇 |
2011年 | 13篇 |
2010年 | 4篇 |
2009年 | 4篇 |
2008年 | 7篇 |
2007年 | 3篇 |
2006年 | 2篇 |
2005年 | 3篇 |
2004年 | 7篇 |
2003年 | 8篇 |
2002年 | 4篇 |
2001年 | 5篇 |
2000年 | 4篇 |
1999年 | 10篇 |
1993年 | 1篇 |
1992年 | 4篇 |
1991年 | 1篇 |
1990年 | 4篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 3篇 |
1983年 | 1篇 |
1979年 | 2篇 |
1976年 | 1篇 |
1975年 | 3篇 |
1974年 | 3篇 |
1972年 | 5篇 |
1969年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有150条查询结果,搜索用时 296 毫秒
51.
Albertelli M. Dotto A. Di Dato C. Malandrino P. Modica R. Versari A. Colao A. Ferone D. Faggiano A. 《Reviews in endocrine & metabolic disorders》2021,22(3):563-579
Reviews in Endocrine and Metabolic Disorders - Peptide receptor radionuclide therapy (PRRT) has been strengthened since the publication of NETTER-1. Nevertheless, the correct positioning in the... 相似文献
52.
Cevenini E. Cotichini R. Stazi M. A. Toccaceli V. Palmas M. G. Capri M. De Rango F. Dato S. Passarino G. Jeune B. Franceschi C. 《Age (Dordrecht, Netherlands)》2014,36(2):949-966
GeroScience - In a scenario of increasing life expectancy worldwide, it is mandatory to identify the characteristics of a healthy aging phenotype, including survival predictors, and to disentangle... 相似文献
53.
54.
Rose G Dato S Altomare K Bellizzi D Garasto S Greco V Passarino G Feraco E Mari V Barbi C BonaFe M Franceschi C Tan Q Boiko S Yashin AI De Benedictis G 《Experimental gerontology》2003,38(10):1065-1070
The human sirtuin 3 (SIRT3) gene encodes a putative mitochondrial NAD-dependent deacetylase (SIRT3) which belongs to the evolutionary conserved family of sirtuin 2 proteins. Studies in model organisms have demonstrated that SIR2 genes control lifespan, while no data are available regarding a possible role of SIRT3 in human longevity. By analysing the genotype-specific survival function relevant to the G477T marker of SIRT3, we found that in males the TT genotype increases (p=0.0272), while the GT genotype decreases (p=0.0391) survival in the elderly. Since SIRT3 lies in a chromosomal region (11p15.5) where four genes potentially associated with longevity are located (HRAS1, Insulin-like Growth Factor 2, Proinsulin, and Tyrosine Hydroxylase) we tested for linkage-disequilibrium between G477T alleles and alleles of the above genes. The disequilibrium was not significant in any case, thus suggesting that SIRT3 itself, or a gene strictly linked to SIRT3, may have a role in human longevity. 相似文献
55.
Gianfrilli D Lauretta R Di Dato C Graziadio C Pozza C De Larichaudy J Giannetta E Isidori AM Lenzi A 《Andrologia》2012,44(Z1):600-604
The application of nutraceuticals in the field of male sexual function -in particular for erectile dysfunction (ED)--remains relatively underexplored. In a group of 54 unselected men (35-75 years), consecutively presenting to our ED clinic and naive to other ED treatments, we carried out a single-blind, one-arm study to evaluate the effects of a 3-month supplementation with propionyl-L-carnitine, L-arginine and niacin on their sexual performance. All patients had the short-international index of erectile function (IIEF) questionnaire, global assessment questions (GAQs) and routine laboratory testing, at baseline and 3 months afterward. 51 (92%) patients of 54 completed the entire study period. After 3 months of treatment, a small, but statistically significant improvement in total and single items of the IIEF was found (Δ = 5.7 ± 4.1 P < 0.01). Analyses on GAQs revealed that treatment improved erections in 40% of cases, with a partial response occurring in up to 77% of subjects enrolled. These preliminary findings indicate that the favourable cardiovascular effects of nutraceuticals might also reflect on male sexual function with possible implication in the treatment and prevention of ED. This study documents a considerable patient's interest toward nutritional supplementation--as first-line or adjunctive treatment to PDE5 inhibitors--that goes beyond the measurable increment in penile rigidity. 相似文献
56.
Soerensen M Dato S Tan Q Thinggaard M Kleindorp R Beekman M Jacobsen R Suchiman HE de Craen AJ Westendorp RG Schreiber S Stevnsner T Bohr VA Slagboom PE Nebel A Vaupel JW Christensen K McGue M Christiansen L 《Experimental gerontology》2012,47(5):379-387
Here we explore association with human longevity of common genetic variation in three major candidate pathways: GH/IGF-1/insulin signaling, DNA damage signaling and repair and pro/antioxidants by investigating 1273 tagging SNPs in 148 genes composing these pathways. In a case-control study of 1089 oldest-old (age 92-93) and 736 middle-aged Danes we found 1 pro/antioxidant SNP (rs1002149 (GSR)), 5 GH/IGF-1/INS SNPs (rs1207362 (KL), rs2267723 (GHRHR), rs3842755 (INS), rs572169 (GHSR), rs9456497 (IGF2R)) and 5 DNA repair SNPs (rs11571461 (RAD52), rs13251813 (WRN), rs1805329 (RAD23B), rs2953983 (POLB), rs3211994 (NTLH1)) to be associated with longevity after correction for multiple testing. In a longitudinal study with 11 years of follow-up on survival in the oldest-old Danes we found 2 pro/antioxidant SNPs (rs10047589 (TNXRD1), rs207444 (XDH)), 1 GH/IGF-1/INS SNP (rs26802 (GHRL)) and 3 DNA repair SNPs (rs13320360 (MLH1), rs2509049 (H2AFX) and rs705649 (XRCC5)) to be associated with mortality in late life after correction for multiple testing. When examining the 11 SNPs from the case-control study in the longitudinal data, rs3842755 (INS), rs13251813 (WRN) and rs3211994 (NTHL1) demonstrated the same directions of effect (p<0.05), while rs9456497 (IGF2R) and rs1157146 (RAD52) showed non-significant tendencies, indicative of effects also in late life survival. In addition, rs207444 (XDH) presented the same direction of effect when inspecting the 6 SNPs from the longitudinal study in the case-control data, hence, suggesting an effect also in survival from middle age to old age. No formal replications were observed when investigating the 11 SNPs from the case-control study in 1613 oldest-old (age 95-110) and 1104 middle-aged Germans, although rs11571461 (RAD52) did show a supportive non-significant tendency (OR=1.162, 95% CI=0.927-1.457). The same was true for rs10047589 (TNXRD1) (HR=0.758, 95%CI=0.543-1.058) when examining the 6 SNPs from the longitudinal study in a Dutch longitudinal cohort of oldest-old (age 85+, N=563). In conclusion, the present candidate gene based association study, the largest to date applying a pathway approach, not only points to potential new longevity loci, but also underlines the difficulties of replicating association findings in independent study populations and thus the difficulties in identifying universal longevity polymorphisms. 相似文献
57.
Giuseppe Gabriele Iorio Alessandro Conforti Roberta Vallone Luigi Carbone Margherita Matarazzo Anna De Rosa Pasquale De Rosa Silvia Picarelli Flora Fedele Giuseppe Perruolo Pietro Formisano Raffaele Iorio Carlo Alviggi Fabiola Di Dato 《Reproductive biomedicine online》2021,42(4):835-841
Research questionWilson's disease (WD) is a disorder of copper metabolism that can cause hormonal alterations. The impact of WD and its therapies on fertility is not well defined. The aim of this study was to evaluate ovarian reserve and sperm parameters in long-term treated WD patients with hepatic onset.DesignWD patients with hepatic onset treated for at least 5 years were compared with healthy controls. Men underwent spermiogram and sperm DNA fragmentation (SDF) analysis. Women were tested for serum FSH, anti-Müllerian hormone (AMH) and sonographic antral follicle count (AFC) in the early follicular phase. Ovulation was monitored with ultrasound and progesterone serum concentrations in the luteal phase.ResultsThe WD group included 26 patients (12 males), the control group 19 subjects (9 males). All patients apart from four (one male) were responders to WD treatment. Sperm count and morphology were comparable between cases and controls. Sperm motility (total and after 1 h) was significantly lower in cases (44.78 ± 21.65%; 47.85 ± 21.52%) than controls (61.88 ± 11.03; 69.44 ± 11.02%, P = 0.03 and 0.01, respectively). The only non-responder had severe oligo-astheno-teratozoospermia. SDF values were normal in cases and controls. AMH, AFC and FSH did not differ between cases and controls. LH was significantly lower in cases (3.36 ± 1.65 mIU/ml) than controls (6.25 ± 1.03 mIU/ml, P < 0.0001). A non-responder woman who developed neurological signs had a 7-year history of infertility.ConclusionsWD patients with hepatic onset, diagnosed early and treated, have no impairment in fertility potential even if males show reduced sperm motility and females lower LH values. Only patients with poor disease control have some evidence of impaired fertility. 相似文献
58.
59.
60.
Karen K. Wong Adena Greenbaum Maria E. Moll James Lando Erin L. Moore Rahul Ganatra Matthew Biggerstaff Eugene Lam Erica E. Smith Aaron D. Storms Jeffrey R. Miller Virginia Dato Kumar Nalluswami Atmaram Nambiar Sharon A. Silvestri James R. Lute Stephen Ostroff Kathy Hancock Alicia Branch Susan C. Trock Alexander Klimov Bo Shu Lynnette Brammer Scott Epperson Lyn Finelli Michael A. Jhung 《Emerging infectious diseases》2012,18(12):1937-1944